REZUROCK (belumosudil) tablets. FDA Approved

FDA approved Anti-Cancer medicine REZUROCK (belumosudil) tablets is available upon request. Get best retail price of REZUROCK (belumosudil) tablets from trusted online pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email urgent@medvitaz.com. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Hematologist.
Category: .

REZUROCK (belumosudil) tablets, for oral use. Initial U.S. Approval: 2021

U.S. FDA Grants Full Approval of REZUROCK™ (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD)
INDICATIONS AND USAGE
REZUROCK is a kinase inhibitor indicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.
DOSAGE FORMS AND STRENGTHS: Tablet: 200 mg
Manufactured By: Kadmon Pharmaceuticals, LLC
Prescribing Information URL: Click Here

HOW TO MAKE AN ENQUIRY FOR REZUROCK (belumosudil) tablets?

FDA approved Anti-Cancer medicine REZUROCK (belumosudil) tablets is available upon request. Get best retail price of REZUROCK (belumosudil) tablets from trusted online pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email urgent@medvitaz.com. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Hematologist.

 

About cGVHD
cGVHD is a complication that can occur following allogeneic stem cell transplantation, resulting in significant morbidity and mortality. In cGVHD, transplanted immune cells (graft) attack the patient's cells (host), leading to inflammation and fibrosis in multiple tissues, including skin, mouth, eye, joints, liver, lung, esophagus and gastrointestinal tract. Approximately 14,000 patients in the United States are living with cGVHD.

About REZUROCK™ (belumosudil)
REZUROCK™ (belumosudil) is the first and only approved therapy targeting Rho-associated coiled-coil kinase 2 (ROCK2), a signaling pathway that modulates inflammatory response and fibrotic processes. REZUROCK is approved in the United States for the treatment of adult and pediatric patients 12 years and older with cGVHD after failure of at least two prior lines of systemic therapy. For more information, visit www.REZUROCK.com.

Kadmon is also developing belumosudil for the treatment of systemic sclerosis. The FDA has granted Orphan Drug Designation to belumosudil for the treatment of systemic sclerosis.

HOW AND WHERE TO BUY belumosudil Tablets?

You can order belumosudil tablets direct from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery. To get best retail price/cost of belumosudil tablets in India, Call 8750295029 or Email urgent@medvitaz.comFDA approved drugs of Australia, Canada, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.